Migraine with Aura Characterized as Independent Risk Factor for Atrial Fibrillation
September 22, 2022

Adults with migraine with aura were found at significantly greater risk for AF and those younger than age 55 years were particularly vulnerable, write Mayo Clinic investigators.

Novel Rapid-acting Treatment for Major Depressive Disorder First to Get FDA Nod
August 25, 2022

The dextromethorphan HBr-bupropion HCI combination uses the first new oral MOA in 6 decades and is labeled to improve depressive symptoms starting at 1 week.

Episode 16: Impact of Cannabis on Brain Health
June 29, 2022

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Henry Mahncke, PhD, on the impact of cannabis on cognitive health.

Gepant sNDA for Chronic Migraine: Atogepant from AbbVie
June 28, 2022

If the atogepant label is expanded, the drug will be the only gepant approved for the broad indication of prevention of both episodic and chronic migraine.

What’s Next in Brain Health? Lifestyle Interventions, Says One Expert
May 11, 2022

Henry Mahncke, PhD, explains why lifestyle interventions, such as diet and exercise, could be prescribed down the line to improve brain health.

Intranasal Insulin Could Help Slow Age-related Cognitive Decline, Suggests a New Study
May 03, 2022

Treatment with intranasal insulin improved executive function and verbal memory, as well as other measures, in participants with and without type 2 diabetes.

"Migraine is a Tremendously Rewarding Disease to Treat"
April 22, 2022

Yale headache specialist Christopher Gottschalk, MD, talks about the opportunities to make a marked difference in the quality of patients' lives.

Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
April 12, 2022

US patients diagnosed with migraine: 40 million. US headache specialists: 600. Primary care is the answer, according to Christopher Gottschalk, MD.

Gepants for Migraine Prevention: A Perfect Fit for Primary Care
March 30, 2022

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with headache specialist Peter McAllister, MD.

Migraine Medicine Transformed: Christopher Gottschalk, MD Discusses How We Got to CGRP Inhibition
March 28, 2022

Gottschalk says CGRP inhibitors have made "...a life-changing transformation in how we think about and the kind of expectations we set for migraine treatment."